Asima Cheema

Cancer immunoediting: from immunosurveillance to tumor escape

Biology of the human malignant lymphomas I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Inhibition of Cellular Mediated Immunity in Marihuana Smokers

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Epstein-Barr virus DNA in human lymphoid cell lines: In vitro conversion

Passive Immunotherapy of Cancer in Animals and Man

The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy

Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)

Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.

Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis

Local tumor immunotherapy with in vitro activated autochthonous lymphocytes